Ballentine Partners’s Stericycle Inc SRCL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
-2,356
Closed -$182K 470
2017
Q2
$182K Sell
2,356
-310
-12% -$25.5K 0.01% 357
2017
Q1
$221K Sell
2,666
-2,775
-51% -$223K 0.02% 216
2016
Q4
$501K Buy
5,441
+777
+17% +$58.7K 0.04% 113
2016
Q3
$374K Sell
4,664
-1,414
-23% -$128K 0.03% 123
2016
Q2
$633K Sell
6,078
-4
-0.1% -$428 0.05% 92
2016
Q1
$767K Buy
6,082
+1,658
+37% +$193K 0.07% 81
2015
Q4
$534K Sell
4,424
-285
-6% -$36.3K 0.05% 93
2015
Q3
$656K Buy
4,709
+289
+7% +$40.2K 0.07% 74
2015
Q2
$592K Hold
4,420
0.06% 78
2015
Q1
$621K Sell
4,420
-1,222
-22% -$165K 0.06% 78
2014
Q4
$740K Buy
5,642
+2,200
+64% +$277K 0.09% 67
2014
Q3
$401K Hold
3,442
0.05% 94
2014
Q2
$408K Sell
3,442
-215
-6% -$24.6K 0.05% 92
2014
Q1
$415K Hold
3,657
0.05% 85
2013
Q4
$425K Hold
3,657
0.05% 89
2013
Q3
$422K Hold
3,657
0.05% 84
2013
Q2
$404K Buy
+3,657
New +$397K 0.05% 72

Other funds holding SRCL

Ballentine Partners's SRCL Position: Q3 2017 in Review

Ballentine Partners sold out of Stericycle Inc (SRCL) in Q3 2017, closing a stake of 2,356 shares — an estimated $182K sold.

Ballentine Partners first reported a position in SRCL in Q2 2013 and held it in 17 quarters. The position peaked at $767K in Q1 2016. 544 funds tracked by Wall St. Rank hold SRCL as of Q3 2017.

  • Ballentine Partners reported no remaining Stericycle Inc position as of Q3 2017 after selling out during the quarter.
  • Ballentine Partners sold 2,356 Stericycle Inc shares in Q3 2017, an estimated $182K.
  • Ballentine Partners first reported a position in Stericycle Inc in Q2 2013 and held it in 17 quarters.
  • Ballentine Partners's Stericycle Inc position peaked at $767K in Q1 2016.
  • 544 funds tracked by Wall St. Rank held Stericycle Inc as of Q3 2017.

Based on Ballentine Partners's 13F filing for Q3 2017, filed 6 Nov 2017.